Screener
Ginkgo Bioworks DNA Government and defense — Concentration risk
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Government and defense | 45% | 21% | 41% | 19% |
| Pharmaceutical and biotechnology | 20 | 44 | 29 | 38 |
| Agriculture | 20 | 23 | 16 | 32 |
| Food and nutrition | 7 | 6 | 7 | 5 |
| Consumer and technology | 6 | 2 | 3 | 1 |
| Industrial and environment | 2 | 4 | 4 | 5 |
| Total revenue | 100% | 100% | 100% | 100% |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's government and defense — concentration risk?
- Ginkgo Bioworks (DNA) reported government and defense — concentration risk of 45% in Q2 2026.
- How has Ginkgo Bioworks's government and defense — concentration risk changed year-over-year?
- Ginkgo Bioworks's government and defense — concentration risk increased by 114.3% year-over-year, from 21% to 45%.
- What is the long-term trend for Ginkgo Bioworks's government and defense — concentration risk?
- Over 2 years (2021 to 2025), Ginkgo Bioworks's government and defense — concentration risk has grown at a 209.4% compound annual growth rate (CAGR), from 7% to 67%.
- What does government and defense — concentration risk mean?
- This metric measures the proportion of total segment revenue derived from government and defense contracts, highlighting the company's reliance on public sector funding. A high concentration indicates significant exposure to legislative budget cycles, policy shifts, and geopolitical priorities. Monitoring this ratio helps investors assess the stability and predictability of cash flows within the specific business unit.
Ask your AI about Ginkgo Bioworks's government and defense — concentration risk.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude